Affymax Announces Upcoming Webcasts and Conference Participation.

PALO ALTO, Calif. -- Affymax, Inc. (Nasdaq:AFFY) today announced that Arlene Morris, the company's president and chief executive officer, will present at the following investor conferences in April and May.

Morgan Stanley Global Healthcare Unplugged Conference
The Ritz-Carlton, Key Biscayne, Fla.
Wednesday, April 30, 2008
11:10 a.m. ET

2008 Citi Investment Research Global Health Care Conference
Hilton New York Hotel
Wednesday, May 21, 2008
10:00 a.m. ET

A live webcast of the presentations will be available on the investors section of the company's website at www.affymax.com. A replay will also be available for 30 days following the presentations.

About Affymax, Inc.

Affymax, Inc. is a biopharmaceutical company developing novel drugs to improve the treatment of serious and often life-threatening conditions. Affymax's lead product candidate, Hematide[TM], is currently in Phase 3 clinical trials for the treatment of anemia associated with chronic renal failure and in a Phase 1 clinical trial for the treatment of anemia in cancer patients. For additional information, please visit www.affymax.com.